Article Details

Prometheus upsizes IPO, fueling chase of Pfizer in bowel disease

Retrieved on: 2021-03-12 13:30:00

Tags for this article:

Click the tags to see associated articles and topics

Prometheus upsizes IPO, fueling chase of Pfizer in bowel disease. View article details on hiswai:

Excerpt

The antibody hits the same target as Pfizer's PF-06480605. Pfizer has already put PF-06480605 through a clutch of early-phase trials and began a 240- ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up